Logo image of METCB

RAMACO RESOURCES INC-B (METCB) Stock Fundamental Analysis

NASDAQ:METCB - Nasdaq - US75134P5017 - Common Stock - Currency: USD

12.64  -0.94 (-6.92%)

Fundamental Rating

4

Overall METCB gets a fundamental rating of 4 out of 10. We evaluated METCB against 157 industry peers in the Metals & Mining industry. While METCB is still in line with the averages on profitability rating, there are concerns on its financial health. METCB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

METCB had negative earnings in the past year.
METCB had a positive operating cash flow in the past year.
METCB had positive earnings in 4 of the past 5 years.
METCB had a positive operating cash flow in each of the past 5 years.
METCB Yearly Net Income VS EBIT VS OCF VS FCFMETCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of METCB (-0.04%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -0.08%, METCB is in line with its industry, outperforming 55.41% of the companies in the same industry.
The Return On Invested Capital of METCB (0.18%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for METCB is above the industry average of 11.75%.
The 3 year average ROIC (14.58%) for METCB is well above the current ROIC(0.18%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.04%
ROE -0.08%
ROIC 0.18%
ROA(3y)11.16%
ROA(5y)8.69%
ROE(3y)20.96%
ROE(5y)15.77%
ROIC(3y)14.58%
ROIC(5y)N/A
METCB Yearly ROA, ROE, ROICMETCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

In the last couple of years the Profit Margin of METCB has declined.
The Operating Margin of METCB (0.21%) is comparable to the rest of the industry.
METCB's Operating Margin has declined in the last couple of years.
METCB has a Gross Margin (19.19%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of METCB has declined.
Industry RankSector Rank
OM 0.21%
PM (TTM) N/A
GM 19.19%
OM growth 3Y-43.63%
OM growth 5Y-27.9%
PM growth 3Y-50.73%
PM growth 5Y-31.1%
GM growth 3Y-13.69%
GM growth 5Y-7.46%
METCB Yearly Profit, Operating, Gross MarginsMETCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so METCB is still creating some value.
The number of shares outstanding for METCB has been increased compared to 1 year ago.
The number of shares outstanding for METCB has been increased compared to 5 years ago.
Compared to 1 year ago, METCB has a worse debt to assets ratio.
METCB Yearly Shares OutstandingMETCB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
METCB Yearly Total Debt VS Total AssetsMETCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.44 indicates that METCB is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.44, METCB is in line with its industry, outperforming 49.68% of the companies in the same industry.
The Debt to FCF ratio of METCB is 2.90, which is a good value as it means it would take METCB, 2.90 years of fcf income to pay off all of its debts.
METCB has a better Debt to FCF ratio (2.90) than 77.07% of its industry peers.
METCB has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
METCB's Debt to Equity ratio of 0.33 is on the low side compared to the rest of the industry. METCB is outperformed by 63.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.9
Altman-Z 2.44
ROIC/WACC0.02
WACC9.33%
METCB Yearly LT Debt VS Equity VS FCFMETCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

METCB has a Current Ratio of 1.32. This is a normal value and indicates that METCB is financially healthy and should not expect problems in meeting its short term obligations.
METCB has a Current ratio of 1.32. This is in the lower half of the industry: METCB underperforms 74.52% of its industry peers.
A Quick Ratio of 0.87 indicates that METCB may have some problems paying its short term obligations.
METCB has a Quick ratio of 0.87. This is in the lower half of the industry: METCB underperforms 74.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.87
METCB Yearly Current Assets VS Current LiabilitesMETCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

METCB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -106.30%.
METCB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.73% yearly.
Looking at the last year, METCB shows a very negative growth in Revenue. The Revenue has decreased by -10.23% in the last year.
Measured over the past years, METCB shows a very strong growth in Revenue. The Revenue has been growing by 23.68% on average per year.
EPS 1Y (TTM)-106.3%
EPS 3Y-43.98%
EPS 5Y-23.73%
EPS Q2Q%-480%
Revenue 1Y (TTM)-10.23%
Revenue growth 3Y32.97%
Revenue growth 5Y23.68%
Sales Q2Q%-22.02%

3.2 Future

Based on estimates for the next years, METCB will show a very strong growth in Earnings Per Share. The EPS will grow by 57.69% on average per year.
METCB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.97% yearly.
EPS Next Y-381.35%
EPS Next 2Y173.81%
EPS Next 3Y82.7%
EPS Next 5Y57.69%
Revenue Next Year-3.06%
Revenue Next 2Y9.98%
Revenue Next 3Y6.96%
Revenue Next 5Y9.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
METCB Yearly Revenue VS EstimatesMETCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
METCB Yearly EPS VS EstimatesMETCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

5

4. Valuation

4.1 Price/Earnings Ratio

METCB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 10.54, the valuation of METCB can be described as reasonable.
Based on the Price/Forward Earnings ratio, METCB is valued a bit cheaper than 73.25% of the companies in the same industry.
METCB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.21.
Industry RankSector Rank
PE N/A
Fwd PE 10.54
METCB Price Earnings VS Forward Price EarningsMETCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, METCB is valued a bit cheaper than 63.69% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, METCB is valued cheaper than 84.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.05
EV/EBITDA 11.9
METCB Per share dataMETCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

METCB's earnings are expected to grow with 82.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y173.81%
EPS Next 3Y82.7%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.36%, METCB is a good candidate for dividend investing.
METCB's Dividend Yield is rather good when compared to the industry average which is at 2.91. METCB pays more dividend than 96.18% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, METCB pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.36%

5.2 History

The dividend of METCB is nicely growing with an annual growth rate of 27.51%!
METCB has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)27.51%
Div Incr Years1
Div Non Decr Years1
METCB Yearly Dividends per shareMETCB Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

METCB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of METCB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-6316.16%
EPS Next 2Y173.81%
EPS Next 3Y82.7%
METCB Yearly Income VS Free CF VS DividendMETCB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

RAMACO RESOURCES INC-B

NASDAQ:METCB (8/1/2025, 8:00:00 PM)

12.64

-0.94 (-6.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-06 2025-08-06/amc
Inst Owners50.72%
Inst Owner Change0.2%
Ins Owners10.57%
Ins Owner ChangeN/A
Market Cap691.41M
Analysts84.44
Price Target10.5 (-16.93%)
Short Float %0.55%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield 8.36%
Yearly Dividend0.46
Dividend Growth(5Y)27.51%
DP-6316.16%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-30 2025-05-30 (0.1811)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.48%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)0.57%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)4.93%
Revenue beat(8)6
Avg Revenue beat(8)2.52%
Revenue beat(12)7
Avg Revenue beat(12)-0.22%
Revenue beat(16)8
Avg Revenue beat(16)1.33%
PT rev (1m)21.02%
PT rev (3m)-16.36%
EPS NQ rev (1m)4.29%
EPS NQ rev (3m)-572.92%
EPS NY rev (1m)-6.6%
EPS NY rev (3m)-269.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.35%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-6.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.54
P/S 1.1
P/FCF 16.05
P/OCF 6.09
P/B 1.95
P/tB 1.95
EV/EBITDA 11.9
EPS(TTM)-0.08
EYN/A
EPS(NY)1.2
Fwd EY9.49%
FCF(TTM)0.79
FCFY6.23%
OCF(TTM)2.08
OCFY16.42%
SpS11.49
BVpS6.49
TBVpS6.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.04%
ROE -0.08%
ROCE 0.24%
ROIC 0.18%
ROICexc 0.2%
ROICexgc 0.2%
OM 0.21%
PM (TTM) N/A
GM 19.19%
FCFM 6.86%
ROA(3y)11.16%
ROA(5y)8.69%
ROE(3y)20.96%
ROE(5y)15.77%
ROIC(3y)14.58%
ROIC(5y)N/A
ROICexc(3y)15.87%
ROICexc(5y)N/A
ROICexgc(3y)15.87%
ROICexgc(5y)N/A
ROCE(3y)18.97%
ROCE(5y)N/A
ROICexcg growth 3Y-40.45%
ROICexcg growth 5Y-26.7%
ROICexc growth 3Y-40.45%
ROICexc growth 5Y-26.7%
OM growth 3Y-43.63%
OM growth 5Y-27.9%
PM growth 3Y-50.73%
PM growth 5Y-31.1%
GM growth 3Y-13.69%
GM growth 5Y-7.46%
F-Score3
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.9
Debt/EBITDA 1.7
Cap/Depr 103.66%
Cap/Sales 11.21%
Interest Coverage 250
Cash Conversion 163.86%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.87
Altman-Z 2.44
F-Score3
WACC9.33%
ROIC/WACC0.02
Cap/Depr(3y)185.43%
Cap/Depr(5y)157.51%
Cap/Sales(3y)14.68%
Cap/Sales(5y)13.82%
Profit Quality(3y)180.81%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.3%
EPS 3Y-43.98%
EPS 5Y-23.73%
EPS Q2Q%-480%
EPS Next Y-381.35%
EPS Next 2Y173.81%
EPS Next 3Y82.7%
EPS Next 5Y57.69%
Revenue 1Y (TTM)-10.23%
Revenue growth 3Y32.97%
Revenue growth 5Y23.68%
Sales Q2Q%-22.02%
Revenue Next Year-3.06%
Revenue Next 2Y9.98%
Revenue Next 3Y6.96%
Revenue Next 5Y9.97%
EBIT growth 1Y-97.99%
EBIT growth 3Y-25.04%
EBIT growth 5Y-10.82%
EBIT Next Year746.54%
EBIT Next 3Y153.3%
EBIT Next 5Y97.62%
FCF growth 1Y744.92%
FCF growth 3Y22.57%
FCF growth 5YN/A
OCF growth 1Y-13.94%
OCF growth 3Y28.34%
OCF growth 5Y21.59%